Renal functional reserve in obesity hypertension

International Journal of Clinical Practice

Volumn 60, Issue 10, 2006, Pages 1198-1203

  Pecly, I M D ^a   Genelhu, V ^a   Francischetti, Emilio Antonio ^a,b  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Hypertension; Kinins; Nitric oxide; Obesity; Renal reserve

Indexed keywords

KALLIKREIN; NITRIC OXIDE; PROTEIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KALLIKREIN URINE LEVEL; KIDNEY BLOOD FLOW; KIDNEY CONCENTRATING CAPACITY; KIDNEY DYSFUNCTION; LEAN BODY WEIGHT; MALE; MEAN ARTERIAL PRESSURE; OBESITY; PRIORITY JOURNAL; PROTEIN INTAKE; QUANTITATIVE ANALYSIS; VASODILATATION;

DIETARY PROTEINS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION, RENAL; KALLIKREINS; MALE; MIDDLE AGED; NITRIC OXIDE; OBESITY; RENAL CIRCULATION;

EID: 33748585508     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01037.x     Document Type: Article

References (41)

1. O'Connor WJ, Summerill RA. The effect of a meal of meat on glomerular filtration rate in dogs at normal urine flows. J Physiol (Lond) 1976; 256: 81-91.
2. Bergström J, Ahlberg M, Alvestrand A. Influence of protein intake on renal hemodynamics and plasma hormone concentrations in normal subjects. Acta Med Scand 1985; 217: 189-96.
3. Bosch JP, Saccaggi A, Lauer A, Ronco C, Belledomine M, Glabman S. Renal functional reserve in humans. Am J Med 1983; 75: 943-9.
4. Bosch JP, Lauer A, Glabman S. Short-term protein loading in assessment of patients with renal disease. Am J Med 1984; 77: 873-9.
5. Camici M. Functional renal reserve and glomerular hyperfiltration. Minerva Urol Nefrol 2005; 57: 1-7.
6. Bohler J, Gloer D, Reetze-Bonorden P, Keller E, Schollmeyer PJ. Renal functional reserve in elderly patients. Clin Nephrol 1993; 39: 145-50.
7. Memoli B, Libetta C, Sabbatini M, Conte G, Russo D, Giani U, Capone D, Andreucci VE. Renal functional reserve: Its significance in normal and salt depletion. Kidney Int 1991; 49: 1134-40.
8. Earle KA, Seema M, Raymond ND, Elizabeth D, Ramasamyiyer S. Defective nitric oxide production and functional renal reserve in patients with type 2 diabetes who have microalbuminuria of African and Asian compared with white origin. J Am Soc Nephrol 2001; 12: 2125-30.
9. Losito A, Fortunati I, Zampi I, Del Favero A. Impaired renal functional reserve and albuminuria in essential hypertension. Br Med J 1988; 296: 1562-64.
10. King AJ. Nitric oxide and the renal hemodynamic response to proteins. Semin Nephrol 1995; 15: 405-14.
11. Jaffa AA, Harvey JN, Sutherland SE, Margolius HS, Mayfield RK. Renal kallikrein responses to dietary protein: A possible mediator of hyperfiltration. Kidney Int 1989; 36: 1003-10.
12. Zhang R, Reisin E. Obesity-hypertension: The effects on cardiovascular and renal systems. Am J Hypertens 2000; 13: 1308-14.
13. Stamler R, Stamler J, Riedlinger WF, Algera G, Roberts RH. Weight and blood pressure: Findings in hypertension screening of 1million Americans. JAMA 1978; 240: 1607-10.
14. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523-29.
15. Hall JE. Pathophysiology of obesity hypertension. Curr Hypertens Rep 2000; 2: 139-47.
16. Higashi Y, Sasaki S, Nakagawa K, Matsura H, Chayama K, Oshima T. Effect of obesity on endothelium-dependent, nitric oxide-mediated vasodilation in normotensive individuals and patients with essential hypertension. Am J Hypertens 2001; 14: 1038-45.
17. Schnurr E, Lahme W, Küppers H. Measurement of renal clearance of inulin and PAH in the steady state without urine collection. Clin Nephrol 1980; 13: 26-9.
18. De'Oliveira JM, Price DA, Fisher DL, Allan DR, McKnight JA, Williams GH, Hollenberg NK. Autonomy of the renin system in type II diabetes mellitus: Dietary sodium and renal hemodynamic responses to ACE inhibition. Kidney Int 1997; 52: 771-7.
19. White RP, Samson FE, Kan L. Determination of inulin in plasma and urine by use of anthrone. J Lab Clin Med March 1954; 43: 475-8.
20. Tauxe WN. Radioisotopic studies in renal ischemia. In: Stanley JC, Ernst CB, Fry WJ, eds. Renovascular Hypertension. Philadelphia, PA: WB Saunders, 1984: 114-33.
21. Russel CD, Dubovsky EV. Measurement of renal function with radionuclides. J Nucl Med 1989; 30: 2053-58.
22. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 1982; 126: 131-8.
23. Ribstein J, du Cailar G, Mimran A. Combined renal effects of overweight and hypertension. Hypertension 1995; 26: 610-15.
24. Hall JE, Henegar JR, Dwyer TM, Liu J, Silva AA, Ku JJ, Tallam L. Is obesity a major cause of chronic kidney disease ? Advances in Renal Replacement Therapy 2004; 11: 41-54.
25. Braam B. Renal endothelial and macula densa NOS: Integrated response to changes in extracellular fluid volume. Am J Physiol 1999; 276: R1551-61.
26. Guizar JM, Kornhauser C, Malacara JM, Amador N, Barrera JA, Esparza R. Renal functional reserve in patients with recently diagnosed type 2 diabetes mellitus with and without microalbuminuria. Nephron 2001; 87: 223-30.
27. Pluvio C, de Pascale E, Giordano M, Cirillo D, Carone M, Pluvio M, Castellino P, Giordano C. Correlation between glomerular morphology and renal haemodynamic response to amino-acid administration in patients with IgA nephropathy. Nephrol Dial Transplant 1996; 11: 2421-25.
28. Livi R, Teghini L, Pignone A, Generini S, Matucci-Cerinic M, Cagnoni M. Renal functional reserve is impaired in patients with systemic sclerosis without clinical signs of kidney involvement. Ann Rheum Dis 2002; 61: 682-6.
29. Gabbai FB. Renal reserve in patients with high blood pressure. Semin Nephrol 1995; 15: 482-7.
30. O'Connor DT, Tyrell EA, Kailasam MT, Miller LM, Martinez JÁ, Henry RR, Parmer RJ, Gabbai FB. Early alteration in glomerular reserve in humans at genetic risk of essential hypertension. Hypertension 2001; 37: 898-906.
31. De Nicola L, Blantz RC, Gabbai FB. Renal functional reserve in treated an untreated hypertensive rats. Kidney Int 1991; 40: 406-12.
32. Pecly IMD, Fagundes VGA, Francischetti EA. A definite role for the kallikrein-kinin system in the renal hemodynamic response to an oral protein load during the aging process. Nephron 1999; 83: 308-13.
33. Notghi A, Anderton JL. Effect of nifedipine and mefruside on renal reserve in hypertensive patients. Postgrad Med J 1988; 64: 856-9.
34. Montanari A, Ragni G, Vallisa D, Colla R, Serventi M, Fasoli E, Coruzzi P, Novarini A. Abnormal renal hemodynamics after oral protein load in essential hypertension. Kidney Int 1990; 37: 402.
35. Sanai T, Kimura G. Renal functional reserve and sodium sensitivity in essential hypertension. J Lab Clin Med 1996; 128: 89-97.
36. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. J Clin Invest 1998; 97: 2601-10.
37. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-7.
38. Dobrian AD, Davres MJ, Schriver SD, Louterio TJ, Prewitt RJ. Oxidative stress in a rat model of obesity-induced hypertension. Hypertension 2001; 37: 554-60.
39. Jaffa AA, Silva RH, Kim B, Mayfield RK. Modulation of renal kallikrein production by dietary protein in streptozotocin-induced diabetic rats. J Am Soc Nephrol 1996; 7: 721-7.
40. 2 and nitric oxide. Hypertension 1997; 29: 757-62.
41. Whittle BJR, Lopez-Belmonte J, Rees DD. Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation. Br J Pharmacol 1989; 98: 646-52.